In all health districts warranting mass drug administration (MDA), the elimination threshold of trachomatous inflammation—follicular (TF) of less than 5% among children ages 1-9 years has been achieved, MDA has stopped, and has been maintained for at least two years in the absence of MDA as of FY21 (October 2020 - September 2021).
Senegal has made critical advances in interrupting onchocerciasis transmission by completing the stop-MDA epidemiological and entomological surveys in 2019 and 2020. The country is making progress towards stopping MDA in all the endemic river basins once the remaining hotspots are verified as having interrupted transmission.
Senegal has successfully implemented over five rounds of effective (more than 75% coverage) MDA and will conduct a schistosomiasis/soil-transmitted helminthiasis (SCH/STH) impact assessment in eight districts in 2022. Data from this survey will enable Senegal to consider a more focal sub-district MDA.
Standard Disease-Specific Indicators as of FY20
FY20 is October 2019 through September 2020
of ever-endemic districts have stopped MDA as of FY20
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))*
*MDA has stopped in all districts for LF although several awaiting TAS1 results
No ever-endemic districts in post-surveillance phase as of FY20
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
of persons no longer at risk as of FY20 among those who were ever at risk
of ever-endemic districts have stopped MDA
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))*
*MDA has stopped for Trachoma in all districts
of ever-endemic districts in post-surveillance phase as of FY20
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))